Kairon Life Science Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 19-12-2024
- Paid Up Capital ₹ 2.00 Cr
as on 19-12-2024
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 12.88 Cr
as on 19-12-2024
- Revenue %
(FY 2020)
- Profit 28.30%
(FY 2020)
- Ebitda 28.76%
(FY 2020)
- Net Worth -35.57%
(FY 2020)
- Total Assets -37.42%
(FY 2020)
About Kairon Life Science
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹12.88 Cr.
Kamleshbhai Bhadani and Dipak Narola serve as directors at the Company.
- CIN/LLPIN
U32900GJ2018PTC101702
- Company No.
101702
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Apr 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kairon Life Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamleshbhai Bhadani  | Director | 09-Apr-2018 | Current |
| Dipak Narola | Director | 09-Apr-2018 | Current |
Financial Performance of Kairon Life Science.
Kairon Life Science Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 28.3% increase in profit. The company's net worth observed a substantial decline by a decrease of 35.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kairon Life Science?
Unlock access to Kairon Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Kairon Bioengineering Private LimitedActive 1 year 1 day
Kamleshbhai Bhadani and Dipak Narola are mutual person
Charges (Loans)
₹12.88 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 12.88 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2024 | State Bank Of India | ₹12.88 Cr | Open |
How Many Employees Work at Kairon Life Science?
Unlock and access historical data on people associated with Kairon Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kairon Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kairon Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.